Palmera Health Sciences

What Palmera Health Sciences does

Palmera Health Sciences is a US-incorporated private company that operates a cloud-based SaaS platform under the brand BEST Health Science, focused on Health Technology Assessment (HTA), Health Economics and Outcomes Research (HEOR), and the preparation of reimbursement dossiers for medical devices, pharmaceuticals, and digital health products. The platform is designed for three distinct user groups: health technology innovators (medtech, pharma, and digital health companies), healthcare policy and decision makers, and HEOR researchers, with built-in alignment to CHEERS 2022 reporting standards, Cochrane systematic review methodology, and jurisdiction-specific reimbursement templates that support global submissions.

The platform is built on Google Angular and Firebase, runs on a freemium tier structure (free Trial, free Basic BETA, Pro, Enterprise), and is offered alongside professional consulting services. The company holds ISO 27001 certification and is GDPR-compliant, providing a defensible information-security posture for handling sensitive healthcare evidence data. AI-enabled capabilities are integrated into the workflow, including AI-assist for form filling, knowledge retrieval for HEOR/HTA evidence, and process automation across dossier preparation steps.

The business model combines SaaS subscriptions (with the lower tiers serving as a top-of-funnel acquisition channel) and project-based professional services revenue from enterprise engagements. The company markets the platform to a global audience of HTA/HEOR stakeholders and currently operates without disclosed capital raises, named reference customers, or published revenue figures.

Name

Palmera Health Sciences

Legal name

Palmera Health Sciences inc.

Website

https://palmerahealthsciences.com

Company type

Private

Operating status

Operating

Short description

Palmera Health Sciences operates BEST Health Science, a cloud-based SaaS platform for Health Technology Assessment, HEOR, and reimbursement dossier preparation, serving health technology innovators, policy makers, and HEOR researchers globally.

Ownership category

akta.pro rank

Product category

Health Technology Assessment Software

NAICS

Other Scientific and Technical Consulting Services (54169), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090), Services-Prepackaged Software (7372)

akta.pro primary industry

Health Technology Assessment (HTA) & Reimbursement Policy Bodies (HLAJACAF)

Keywords

• Health technology assessment
• Reimbursement dossier software
• HEOR consulting services
• Value dossier builder
• Health evidence platform

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. SaaS Platform Subscriptions: Tiered subscription model with Trial, Basic, Pro, and Enterprise tiers. Basic tier offered free during BETA. Subscriptions differentiated by project limits, user seats, storage, and AI token allocations.
2. AI Token Consumption: Usage-based AI assist features with token allocations. Basic tier includes 50,000 tokens/month, Pro tier includes 200,000 tokens/month. Enterprise likely has custom token arrangements.
3. Professional Services and Consulting: Consulting services including platform support and training, reimbursement submissions support, literature reviews, contextual analysis, and health equity analysis.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Palmera Health Sciences operates the BEST Health Science Platform, a cloud-based SaaS workspace that combines real-time collaboration, AI-assisted form completion, and customizable Global Value Dossier / jurisdiction-specific templates to streamline reimbursement and Health Technology Assessment (HTA) submissions. Complementing the platform, the company sells BEST Health Science Consulting Services covering reimbursement submissions, literature reviews (systematic, rapid, scoping), contextual analysis, and health equity / differential impact assessments for healthcare organizations.

Product overview

Palmera Health Sciences operates as a platform-plus-services company. Its core product is the BEST Health Science Platform — a unified, cloud-based interactive workspace built on Google Angular and Firebase — that combines real-time collaboration tools, intelligent HEOR/HTA guidance, AI-assisted form completion, and customizable dossier-building templates. The platform is sold in four tiers (Trial, Basic, Pro, Enterprise) differentiated by project limits, user seats, token allocations for AI features, storage, and support SLAs. Complementing the software platform, Palmera Health Sciences offers a separate BEST Health Science Consulting Services practice that provides expert methodological support for reimbursement submissions, systematic literature reviews, contextual analysis, and health equity assessments — services that can be used independently or alongside the platform.

Differentiator

Problem solved

Functional benefit

Products and services

• BEST Health Science Platform A cloud-based interactive workspace for health technology innovators, payers, and researchers that combines real-time collaboration, intelligent HEOR/HTA guidance, AI-assisted form completion, and customizable templates for building Global Value Dossiers and jurisdiction-specific reimbursement applications. Sold in tiered subscriptions differentiated by project limits, user seats, AI token allocations, storage, and support SLAs.
• BEST Health Science Consulting Services Tailored expert consulting services covering medical device and drug reimbursement submissions, health services intervention assessments, systematic/rapid/scoping literature reviews with meta-analysis and network meta-analysis, stakeholder engagement, contextual qualitative and quantitative data analysis, and health equity / differential impact assessments. Sold to healthcare organizations and policymakers needing methodological support alongside or independent of the SaaS platform.

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

One partnership is on record.

• GooglecoreTechnology or IntegrationTechnology infrastructure partnership leveraging Google Angular (frontend framework) and Google Firebase (backend, authentication, data management, storage). Firebase provides real-time data handling, encryption, access control, and scalability. Both technologies developed by Google and form the foundation for the platform's responsive, scalable, and secure experience supporting scientific research.

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Trinity Life Sciences: Life sciences strategy and HEOR/market access consultancy with proprietary evidence and forecasting platforms. Competes for the same pharma-sponsored HTA and value strategy engagements.
• ICON plc: Global CRO offering HEOR, market access, and HTA consulting as part of a broad clinical and commercial services portfolio. Competes for the same sponsor budgets Palmera targets.
• IQVIA: Global CRO with a dedicated Real World Evidence and HTA practice serving life sciences sponsors. Competes with Palmera on the consulting side and through internal technology platforms for market access and evidence synthesis.
• Clarivate (Decision Resources Group): Operates DRG and other HTA/market access data, analytics, and consulting franchises. Overlaps Palmera on jurisdiction-specific HTA intelligence, value dossier content, and reimbursement advisory.

Direct peers

• Evidera: A HEOR, market access, and HTA consulting firm (now part of Thermo Fisher Scientific/PPD) that combines deep methodology services with proprietary evidence-generation platforms. Closely comparable to Palmera as a services-plus-software HTA/reimbursement player serving life sciences sponsors.
• Cytel: Provides biostatistics and HEOR/HTA consulting alongside proprietary statistical software (e.g., EAST for adaptive designs). Mirrors Palmera's platform-plus-services combination in the evidence-generation space.
• Mtech Access: UK-based specialist HEOR, market access, and HTA consultancy serving pharma and medtech. Comparable in size and specialization, providing methodological support for reimbursement submissions similar to Palmera's consulting arm.
• PharmaGenesis: Independent HEOR and medical communications consultancy with expertise in value communications, HTA submissions, and evidence synthesis. Competes for the same specialist HTA methodology work.
• Real Chemistry: Healthcare-focused consultancy with a market access and evidence practice serving biopharma on commercialization, HTA, and value storytelling. Direct comparable on the consulting-side value dossier work Palmera supports.

Emerging players

• Sorcero: AI platform for life sciences and medical affairs that applies LLMs to evidence review and content generation. Most direct AI-first peer to Palmera's AI-assisted dossier and horizon-scanning features.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Palmera Health Sciences